Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,145 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00075218 | A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) | completed | Phase 3 | 361 | PfizerINDUSTRY | 11 | Sep 28, 2009 | clinicaltrials |
| NCT00273546 | Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer | completed | Phase 3 | 500 | SanofiINDUSTRY | 6 | Apr 29, 2009 | clinicaltrials |
| NCT00083564 | Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma | terminated | Phase 3 | 240 | Poniard PharmaceuticalsINDUSTRY | 2 | Mar 31, 2009 | clinicaltrials |
| NCT00294996 | Trial of Myocet in Metastatic Breast Cancer | unknown | Phase 3 | 363 | Sopherion TherapeuticsINDUSTRY | 11 | Mar 31, 2009 | clinicaltrials |
| NCT00043576 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | unknown | Phase 2 / Phase 3 | 250 | NovaceaINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00299039 | T3AI-Pain After Breast Surgery(T3AI) | completed | Phase 3 | 150 | Nova Scotia Health AuthorityOTHER | 1 | Feb 2, 2009 | clinicaltrials |
| NCT00156026 | Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1 | completed | Phase 3 | 415 | Ontario Clinical Oncology Group (OCOG)OTHER | 2 | Jan 29, 2009 | clinicaltrials |
| NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | terminated | Phase 3 | 248 | Helsinn Healthcare SAINDUSTRY | 11 | Jan 14, 2009 | clinicaltrials |
| NCT00089856 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | terminated | Phase 3 | 626 | Cell GenesysINDUSTRY | 8 | Nov 5, 2008 | clinicaltrials |
| NCT00133224 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | terminated | Phase 3 | 408 | Cell GenesysINDUSTRY | 10 | Sep 23, 2008 | clinicaltrials |
| NCT00187343 | A Clinical Trial to Reduce Skin Burn Induced by Breast Radiotherapy Using Intensity Modulated Radiation Therapy (IMRT) | completed | Phase 3 | 340 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 8, 2008 | clinicaltrials |
| NCT00111865 | Healthy Exercise for Lymphoma Patients (HELP)(HELP) | unknown | Phase 3 | 122 | Lance Armstrong FoundationOTHER | 1 | Aug 26, 2008 | clinicaltrials |
| NCT00081796 | Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer | completed | Phase 3 | 438 | SanofiINDUSTRY | 26 | Aug 21, 2008 | clinicaltrials |
| NCT00489060 | A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer | completed | Phase 3 | 244 | University of CalgaryOTHER | 1 | Jul 17, 2008 | clinicaltrials |
| NCT00150917 | RCT of a Group Intervention for Women With a Family History of Breast Cancer | completed | Phase 3 | 150 | University Health Network, TorontoOTHER | 1 | Jun 17, 2008 | clinicaltrials |
| NCT00683969 | A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis | completed | Phase 3 | 136 | Hoffmann-La RocheINDUSTRY | 14 | May 26, 2008 | clinicaltrials |
| NCT00068952 | Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme | completed | Phase 3 | 118 | PfizerINDUSTRY | 13 | Apr 1, 2008 | clinicaltrials |
| NCT00226668 | XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema | withdrawn | Phase 3 | 120 | Celtic Pharma Development ServicesINDUSTRY | 2 | Jan 3, 2008 | clinicaltrials |
| NCT00165087 | Treatment of Childhood Acute Lymphoblastic Leukemia | terminated | Phase 3 | 491 | Dana-Farber Cancer InstituteOTHER | 3 | Dec 28, 2007 | clinicaltrials |
| NCT00146211 | TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease | completed | Phase 3 | 300 | Amarin Neuroscience LtdINDUSTRY | 2 | Dec 27, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00273338 | DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | terminated | Phase 3 | 1,200 | NovaceaINDUSTRY | 9 | Nov 6, 2007 | clinicaltrials |
| NCT00548600 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | completed | Phase 3 | 112 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 24, 2007 | clinicaltrials |
| NCT00201942 | PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial) | completed | Phase 3 | 336 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Oct 18, 2007 | clinicaltrials |
| NCT00044759 | Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma | completed | Phase 3 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 2 | Oct 10, 2007 | clinicaltrials |
| NCT00267553 | Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer | terminated | Phase 3 | 200 | Intarcia TherapeuticsINDUSTRY | 4 | Sep 10, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00294151 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | unknown | Phase 3 | 30 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jul 13, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00207324 | The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions | completed | Phase 3 | 100 | British Columbia Cancer AgencyOTHER | 1 | Jun 27, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00135876 | Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | completed | Phase 3 | 512 | Ontario Clinical Oncology Group (OCOG)OTHER | 4 | Apr 27, 2007 | clinicaltrials |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma | completed | Phase 3 | 240 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00175643 | Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses | completed | Phase 3 | 20 | University of British ColumbiaOTHER | 1 | May 9, 2006 | clinicaltrials |
| NCT00290524 | Early Alimentation Following Colorectal Surgery | unknown | Phase 3 | 800 | Maisonneuve-Rosemont HospitalOTHER | 1 | Apr 7, 2006 | clinicaltrials |
| NCT00306033 | Intravenous Immune Globulin Treatment Compared to Placebo in Patients With Myasthenia Gravis | completed | Phase 3 | 50 | University Health Network, TorontoOTHER | 1 | Apr 3, 2006 | clinicaltrials |
| NCT00168740 | Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102) | completed | Phase 3 | 150 | BiogenINDUSTRY | 2 | Sep 15, 2005 | clinicaltrials |
| NCT00175747 | A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide) | completed | Phase 2 / Phase 3 | 120 | University of British ColumbiaOTHER | 1 | Sep 15, 2005 | clinicaltrials |
| NCT00148057 | Diet and Breast Cancer Prevention Trial | completed | Phase 3 | 4,695 | University Health Network, TorontoOTHER | 1 | Sep 7, 2005 | clinicaltrials |
| NCT00002445 | Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients | completed | Phase 3 | 200 | CytranINDUSTRY | 4 | Jun 24, 2005 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | completed | Phase 2 / Phase 3 | 274 | Celgene CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials